A thienotriazolodiazepine compound of the formula: ##STR1## wherein each symbol is as defined in the spedification, or a pharmaceutically acceptable acid addition salt thereof, and pharmaceutically uses thereof. Said compounds exhibit PAF-antagonistic acitivty and are useful for the prevention or treatment of various PAF-induced diseases.
一种
噻唑三氮平化合物的公式为:##STR1## 其中每个符号如规范中所定义,或其药学上可接受的酸加盐,以及其药学用途。该化合物表现出PAF-拮抗活性,可用于预防或治疗各种PAF诱导的疾病。